Bicycle Therapeutics plc ( BCYC) - Key Metrics
BCYC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.69 | -$0.29 | -$0.27 | -$0.25 |
| 2025Q3 | $0.17 | -$0.85 | -$1.03 | -$1.04 |
| 2025Q2 | $0.04 | -$1.14 | -$1.05 | -$1.06 |
| 2025Q1 | $0.14 | -$0.88 | -$1.25 | -$1.26 |
BCYC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.08 |
| 2025Q3 | ? | -2.27 |
| 2025Q2 | ? | -1.52 |
| 2025Q1 | ? | -2.42 |
BCYC
Price: $4.05
52 week price:
Earnings Per Share: -3.24 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 365200
Market Capitalization: 291.5 million